AU2002334836B2 - N-heterocyclyl hydrazides as neurotrophic agents - Google Patents

N-heterocyclyl hydrazides as neurotrophic agents Download PDF

Info

Publication number
AU2002334836B2
AU2002334836B2 AU2002334836A AU2002334836A AU2002334836B2 AU 2002334836 B2 AU2002334836 B2 AU 2002334836B2 AU 2002334836 A AU2002334836 A AU 2002334836A AU 2002334836 A AU2002334836 A AU 2002334836A AU 2002334836 B2 AU2002334836 B2 AU 2002334836B2
Authority
AU
Australia
Prior art keywords
compound
disease
condition
heterocyclyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2002334836A
Other languages
English (en)
Other versions
AU2002334836A1 (en
Inventor
James C Lanter
Mark Macielag
Zhihua Sui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU2002334836A1 publication Critical patent/AU2002334836A1/en
Assigned to ORTHO-MCNEIL PHARMACEUTICAL, INC. reassignment ORTHO-MCNEIL PHARMACEUTICAL, INC. Amend patent request/document other than specification (104) Assignors: ORTHO MC NEIL PHARMACEUTICAL, INC.
Application granted granted Critical
Publication of AU2002334836B2 publication Critical patent/AU2002334836B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2002334836A 2001-10-04 2002-10-04 N-heterocyclyl hydrazides as neurotrophic agents Expired - Fee Related AU2002334836B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32701901P 2001-10-04 2001-10-04
US60/327,019 2001-10-04
PCT/US2002/031678 WO2003029247A1 (en) 2001-10-04 2002-10-04 N-heterocyclyl hydrazides as neurotrophic agents

Publications (2)

Publication Number Publication Date
AU2002334836A1 AU2002334836A1 (en) 2003-06-26
AU2002334836B2 true AU2002334836B2 (en) 2008-04-17

Family

ID=23274781

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002334836A Expired - Fee Related AU2002334836B2 (en) 2001-10-04 2002-10-04 N-heterocyclyl hydrazides as neurotrophic agents

Country Status (10)

Country Link
US (1) US7087628B2 (cg-RX-API-DMAC7.html)
EP (1) EP1448553B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005506335A (cg-RX-API-DMAC7.html)
AT (1) ATE294794T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002334836B2 (cg-RX-API-DMAC7.html)
CA (1) CA2462419A1 (cg-RX-API-DMAC7.html)
DE (1) DE60204046T2 (cg-RX-API-DMAC7.html)
ES (1) ES2242096T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA04003216A (cg-RX-API-DMAC7.html)
WO (1) WO2003029247A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918286B1 (en) * 2006-11-05 2011-12-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thiazolhydrazides for treatment of neurodegenerative diseases
WO2012027548A1 (en) * 2010-08-25 2012-03-01 The Feinstein Institute For Medical Research Compounds and methods for prevention and treatment of alzheimer's and other diseases
EP3515427A4 (en) 2016-09-26 2020-10-14 Qingdao Primedicine Pharmaceutical Co., Ltd N-METHYL D-ASPARTATE RECEPTOR ALLOSTERIC MODULATORS AND METHODS FOR USING THEM
PL233208B1 (pl) * 2018-09-17 2019-09-30 Politechnika Wroclawska Iminowe pochodne aldehydów salicylowych i hydrazydu kwasu 4-hydroksybenzoesowego oraz sposób ich wytwarzania

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665173A (en) * 1982-03-31 1987-05-12 Klayman Daniel L 2-acetyl- and 2-propionylpyridine selenosemicarbazones
US4694004A (en) * 1984-07-09 1987-09-15 Fujisawa Pharmaceutical Co., Ltd. Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
ES2161594B1 (es) * 1998-12-17 2003-04-01 Servier Lab Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
US6544976B1 (en) 1999-07-09 2003-04-08 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
US6323215B1 (en) 1999-07-09 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
HUP0304058A2 (hu) * 2001-01-30 2004-04-28 Bristol-Myers Squibb Company Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények

Also Published As

Publication number Publication date
ATE294794T1 (de) 2005-05-15
CA2462419A1 (en) 2003-04-10
ES2242096T3 (es) 2005-11-01
EP1448553B1 (en) 2005-05-04
MXPA04003216A (es) 2005-01-25
JP2005506335A (ja) 2005-03-03
DE60204046D1 (de) 2005-06-09
US20030144262A1 (en) 2003-07-31
DE60204046T2 (de) 2006-01-19
US7087628B2 (en) 2006-08-08
HK1066223A1 (en) 2005-03-18
WO2003029247A1 (en) 2003-04-10
EP1448553A1 (en) 2004-08-25

Similar Documents

Publication Publication Date Title
JP6622824B2 (ja) キヌレニン−3−モノオキシゲナーゼインヒビターおよびその医薬組成物ならびにこれらの使用方法
EP2964223B1 (en) Compounds inhibiting leucine-rich repeat kinase enzyme activity
KR102204804B1 (ko) 디히드로피라졸 gpr40 조절제
CN112312904A (zh) 螺环化合物
JP2021534106A (ja) Pad4阻害剤としての置換チエノピロール
TW201706265A (zh) 做為Rho激酶(ROCK)抑制劑之內醯胺
EP2257340A2 (en) Compounds for treating muscular dystrophy
CN102264740A (zh) 一种吡咯[1,2-b]哒嗪衍生物及其作为hif调节剂的用途
EP3681877B1 (en) Pyrazole derivative compound and use thereof
JP2014511355A (ja) ヒストンデアセチラーゼ阻害薬並びにその組成物及び使用方法
WO2020233618A1 (zh) 一类细胞程序性坏死抑制剂及其制备方法和用途
CN106068265A (zh) 用于治疗代谢病症的二氢吡啶酮mgat2抑制剂
EP1448553B1 (en) N-heterocyclyl hydrazides as neurotrophic agents
AU2002334836A1 (en) N-heterocyclyl hydrazides as neurotrophic agents
CN112703187A (zh) 作为trk受体的调节剂的4-取代的苯基-1,3,5-三嗪衍生物
WO2016112863A1 (zh) N-取代-3,5-二取代苯甲酰胺类化合物及其制备方法和应用
EP1446127B1 (en) Triazepine derivatives as neurotrophic agents
US6821993B1 (en) Triazepine derivatives as neurotrophic agents
HK1066223B (en) N-heterocyclyl hydrazides as neurotrophic agents
AU2002334837A1 (en) Triazepine derivatives as neurotrophic agents
WO2001004091A1 (en) Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
HK40085749A (en) P2x3 modulators
WO2024153237A1 (zh) 一种igf-1r酪氨酸激酶抑制剂、药物组合物及其用途
WO2024067566A1 (zh) 饱和环类衍生物、包含其的药物组合物及其医药用途
EP1842845A1 (en) Aza-heterocyclic compounds used to treat neurological disorders and hair loss

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE APPLICANT/PATENTEE FROM ORTHO MC NEIL PHARMACEUTICAL, INC. TO ORTHO-MCNEIL PHARMACEUTICAL, INC.

PC1 Assignment before grant (sect. 113)

Free format text: FORMER APPLICANT(S): (25D) 2002341563 (25D) 2002344676 (5C) 2005201131 TRAILERS BY DESIGN PTY LTD THE APPLICATION HAS BEEN